Exact Sciences ( NASDAQ:EXAS – Get Rating ) had its target price increased by analysts at Benchmark from $81.00 to $96.00 in a research note issued to investors on Thursday, The Fly reports. Benchmark's target price indicates a potential upside of 3.65% from the stock's previous close. Several other analysts have also recently issued reports on the stock. UBS Group assumed coverage on shares of Exact Sciences in a research note on Friday, May 5th. They set a 'neutral' rating and a $73.00 price objective for the company.

https://www.dailypolitical.com/2023/06/23/exact-sciences-nasdaqexas-pt-raised-to-96-00-at-benchmark.html

#dailypolitical